Advances in genomics since the first full-length human DNA sequence was published in 2001 mean that we are now seeing many important clinical applications of this data-intense field. Many other ‘omic disciplines are also maturing to the point of clinical application (transcriptomics, proteomics, metabolomics, metagenomics). The rich molecular information yielded by these disciplines, when combined with well-annotated health information, has the potential to provide an unprecedented level of personalized, mechanistically informed care to our patients. We are at a shifting point in evidence-based medicine whereby we can increasingly rely on evidence from an individual, rather than evidence from an average of individuals. Much work is still required to appropriately analyze, understand and validate such vast and diverse amounts of data for the purpose of prevention, accurate diagnosis, and optimal management of disease.
To DoM members: if you are involved in any type of Precision Medicine initiative, we invite you to participate in a survey being conducted through the Cumming School of Medicine. Thank you to those who have already completed the survey. Results from this survey will help the Cumming School of Medicine to: (1) optimally direct resources to support this work as a faculty; (2) educate each other on precision medicine initiatives; (3) better communicate these initiatives to the public. If you have any questions, please contact Christina Hirota (email@example.com).
Dr. Dan Muruve,
Vice Chair, Precision Medicine
Dr. Christina Hirota,
Personalized Medicine Project Coordinator